Yonghong International Biotechnology Q4 2025 Financial Report
Yonghong International Biotechnology Co., Ltd. reported a basic EPS of NT.82 for Q4 2025. The company's operating revenue reached NT.416 billion, with a net profit after tax of NT29 million.
📋 Article Processing Timeline
- 📰 Published: December 1, 2025 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (3047h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:21 (16h 21m after Collected)
Company Code: 6936 Company Name: Yonghong International Biotechnology Co., Ltd. Industry: Biotechnology and Medical Industry Year/Quarter: 2025 Q4 Basic Earnings Per Share: NT.82 Operating Revenue: NT.416 billion Net Profit After Tax: NT29 million